Does Sarcolipin Ablation Alter Deflazacort Treatment Effects in mdx Mice

@inproceedings{Bellissimo2017DoesSA,
  title={Does Sarcolipin Ablation Alter Deflazacort Treatment Effects in mdx Mice},
  author={Catherine A Bellissimo},
  year={2017}
}

References

Publications referenced by this paper.
SHOWING 1-10 OF 177 REFERENCES

Glucocorticoid treatment alleviates dystrophic myofiber pathology by activation of the calcineurin/NF-AT pathway.

  • FASEB journal : official publication of the Federation of American Societies for Experimental Biology
  • 2004
VIEW 10 EXCERPTS
HIGHLY INFLUENTIAL

Regulation of the growth of multinucleated muscle cells by an NFATC2-dependent pathway

V Horsley
  • J Cell Biol,
  • 2001
VIEW 22 EXCERPTS
HIGHLY INFLUENTIAL

Long-Term Outcome of Interdisciplinary Management of Patients with Duchenne Muscular Dystrophy Receiving Daily Glucocorticoid Treatment

Wong, B.L
  • The Journal of Pediatrics,
  • 2017
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Prednisolone-induced changes in dystrophic skeletal muscle.

  • FASEB journal : official publication of the Federation of American Societies for Experimental Biology
  • 2005
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…